6626-60-4 Usage
Description
(3beta,17beta)-17-(1H-imidazol-5-yl)androst-5-en-3-ol, also known as 5-alpha-androst-3-ol-17-one, is a synthetic androgen and anabolic steroid derived from testosterone, the primary male sex hormone. It functions as a competitive inhibitor of the androgen receptor and has been investigated for its potential therapeutic applications in treating muscle wasting disorders and hormone-related diseases. Additionally, it has been utilized as a performance-enhancing substance in sports and bodybuilding, although its use in these areas is controversial and prohibited by sports organizations and regulatory bodies due to the risk of abuse and negative health impacts.
Uses
Used in Medical Treatments:
(3beta,17beta)-17-(1H-imidazol-5-yl)androst-5-en-3-ol is used as a therapeutic agent for the treatment of muscle wasting disorders and hormone-related diseases, leveraging its androgenic and anabolic properties to promote muscle growth and strength.
Used in Sports and Bodybuilding:
(3beta,17beta)-17-(1H-imidazol-5-yl)androst-5-en-3-ol is used as a performance-enhancing drug in sports and bodybuilding to increase muscle mass and strength. However, its use in these contexts is controversial and banned by various sports organizations and regulatory agencies due to the potential for abuse and adverse health effects.
Check Digit Verification of cas no
The CAS Registry Mumber 6626-60-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,6,2 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6626-60:
(6*6)+(5*6)+(4*2)+(3*6)+(2*6)+(1*0)=104
104 % 10 = 4
So 6626-60-4 is a valid CAS Registry Number.
6626-60-4Relevant articles and documents
17-imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P45017α)
Ling, Yang-Zhi,Li, Ji-Song,Liu, Yang,Kato, Katsuya,Klus, Gregory T.,Brodie, Angela
, p. 3297 - 3304 (2007/10/03)
We recently described a number of inhibitors of P45017α, the key enzyme of androgen biosynthesis. Here, we report the synthesis and activity of novel 17-imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives as potential agents for the tr
